EPCAM and hepatocellular carcinoma: Hoh et al. reported that EpCAM/CD3 bispecific antibody enhanced γδ T cell -mediated lysis of hepatoblastoma and paediatric hepatocellular carcinoma cells in spheroid culture models [131].